SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aanjaneya Lifecare inches up on getting nod for overseas expansion

09 Jan 2012 Evaluate

Aanjaneya Lifecare is currently trading at Rs. 484.50, up by 0.40 points or 0.08% from its previous closing of Rs. 484.10 on the BSE.

The scrip opened at Rs. 485.80 and has touched a high and low of Rs. 488.60 and Rs. 481.50 respectively. So far 1852 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 525.00 on 26-Dec-2011 and a 52 week low of Rs. 224.00 on 27-May-2011.

Last one week high and low of the scrip stood at Rs. 514.00 and Rs. 475.15 respectively. The current market cap of the company is Rs. 609.78 crore.

The promoters holding in the company stood at 60.24% while Institutions and Non-Institutions held 4.57% and 35.19% respectively. 

Aanjaneya Lifecare has received an approval for overseas expansion whereby it has decided to open subsidiary companies and offices in Singapore and UAE. The board at its meeting held on January 09, 2012 has approved for the same.

Further, the board has also authorized the managing director of the company, to negotiate the terms and conditions for acquisition of 100% assets and business of Apex Drugs & Intermediates.

Aanjaneya Lifecare is a leading research based integrated pharmaceutical company with established research, manufacturing and marketing capabilities.  It is R&D focused, has a multi product portfolio with state of the art manufacturing facilities, and is set to become a marketing conglomerate across the globe.

Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×